This Test Guideline describes an in vivo erythrocyte Pig-a gene mutation assay (hereafter called the Pig-a assay) which uses an endogenous mammalian gene, the phosphatidylinositol glycan class A gene (Pig-a), as a reporter of somatic-cell gene mutation. In vivo gene mutation tests, such as the Pig-a assay, are especially relevant for assessing mutagenicity because physiological factors, such as absorption of the test chemical from the site of exposure, distribution of the test chemical throughout the test system via systemic circulation, and in vivo metabolism and DNA repair processes, all contribute to the mutagenic responses. The Pig-a assay can be performed with commonly used strains of rats or mice and the test can be conducted without euthanizing the animals. These properties facilitate integration of the Pig-a assay into many in vivo rodent testing protocols.
Test No. 470: Mammalian Erythrocyte Pig‑a Gene Mutation Assay
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
25 June 202526 Pages
-
25 June 202516 Pages
-
25 June 202519 Pages
-
25 June 202532 Pages
-
25 June 202526 Pages
-
25 June 202536 Pages
-
25 June 202541 Pages
-
25 June 202538 Pages
Related publications
-
15 December 2025169 Pages
-
Report3 December 202594 Pages
-
30 June 2025193 Pages
-
Working paper30 June 2025250 Pages
-
30 June 2025329 Pages
-
Working paper30 June 2025270 Pages